Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2137 of 6351
-
Could an 8-Day therapy course help teens overcome panic and agoraphobia?
Disease control CompletedThis study will evaluate the effectiveness of intensive cognitive behavioral therapy in treating adolescents with panic disorder with agoraphobia.
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can music and movement curb HIV in At-Risk teens?
Prevention CompletedThe purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The inte…
Phase 1/2 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Massive study aims to unlock secrets of inherited Alzheimer's in china
Knowledge-focused Recruiting nowThis research will establish and continuously improve the FAD research network in conjunction with multi-center institutions nationwide. By collecting information on the family's demography, genetics, neuropsychology, neuroimaging, biomarkers and other information, we can underst…
Sponsor: Capital Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Chemo delivered straight to liver shows promise for inoperable cancer
Disease control CompletedThis study is for people with cancer of the liver that cannot be completely removed by surgery. This study involves giving the drugs mitomycin-C and cisplatin, into an artery in the liver. Mitomycin-C is a drug that has been approved by the FDA to treat cancer of the stomach and …
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental vaccine trains immune system to attack kidney tumors
Disease control CompletedThe main purpose of this study is to test the safety of the dendritic cell/tumor fusion study vaccine in combination with a laboratory-made agent called Granulocyte Macrophage Colony Stimulating Factor (GM-CSF). Another purpose is to determine the type and severity of any side ef…
Phase 1/2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Drug that starves tumors shows promise against advanced kidney cancer
Disease control CompletedRATIONALE: Lenalidomide may stop the growth of kidney cancer by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well lenalidomide works in treating patients with advanced or unresectable kidney cancer.
Phase 2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a targeted drug shrink recurrent endometrial tumors?
Disease control CompletedThe goal of this clinical research study is to learn if RAD001 can shrink or slow the growth of tumors in patients who have recurrent endometrial cancer. The safety of this drug will also be studied. Objectives: Primary Objective: 1\. To determine the efficacy of RAD001 in pat…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Immune cell infusion shows promise against post-transplant blood cancer relapse
Disease control CompletedThis is a phase 1 dose escalation study evaluating the use of activated T-cells to treat relapsed malignancy (cancer) following allogeneic hematopoietic cell transplantation, without causing GvHD.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New asthma pill shows promise in major trial
Disease control CompletedThe aim of the study is to investigate the effect of roflumilast (APTA-2217) on lung function in patients with asthma. Roflumilast will be administered orally once daily. The study duration consists of a baseline period (2 to 4 weeks) and a treatment period (24 weeks). The study …
Phase 2/3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThe purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New oral drug cocktail shows promise for kids with resistant neuroblastoma
Disease control CompletedRATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die. Temozolomide may help irinotecan kill more tumor cells by making them more sensitive to the drug. Cefixime may be effe…
Phase 1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Radiation showdown: which schedule beats childhood brain cancer?
Disease control CompletedThis is an international prospective randomised trial, which will compare two radiotherapy regimens in children and adolescents (aged 4 or 5 years to 21 years inclusive) with carefully staged 'standard risk' medulloblastoma.
Phase 3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 26, 2026 17:03 UTC
-
Switching transplant drug may cut skin cancer risk
Disease control CompletedIn a population of kidney transplant recipients having developed a first squamous cell carcinoma, the aim of the study is to assess the incidence of subsequent skin cancers over 2 years in patients who are switched to rapamycin as compared to patients who are maintained under cal…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Simple vitamin pills could cut blood transfusions in pregnant african women
Prevention CompletedThe purpose of this research is to compare the efficacy of two low-cost low intervention packages to prevent and treat severe anemia in pregnant women in Zanzibar, Tanzania. The two packages are Standard of Care as described by the WHO (presumptive treatment for malaria and helmi…
Phase 3 • Sponsor: Cornell University • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Experimental drug RAD001 tested for tough leukemias and lymphomas
Disease control CompletedThe goal of this clinical research study is to find the highest safe dose of RAD001 that can be given as a treatment for leukemia, mantle cell lymphoma, or myelofibrosis. Another goal is to learn how effective the dose that is found is as a treatment.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for rare penile cancer
Disease control CompletedThe purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.
Phase 2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThe goal of this clinical research study is to learn if giving the new drug, Tarceva® (OSI-774), in combination with Platinol® (cisplatin) and Taxotere® (docetaxel) is effective in the treatment of metastatic or recurrent head and neck cancer. The safety of this treatment will al…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Gene expression platform could revolutionize kidney transplant rejection diagnosis
Knowledge-focused CompletedThis retrospective multicentre observational study developed and validated HistoMX, an automated gene-expression-based platform for multidimensional molecular interpretation of kidney allograft biopsies. The study included 2,410 archived post-transplant kidney allograft biopsy s…
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Can heat zapping stop esophagus cancer before it starts?
Disease control By invitation onlyTo assess the effect of ablative therapy (Photodynamic Therapy or Radiofrequency ablation ) on Barrett's Esophagus
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a national registry predict heart attacks in inherited high cholesterol?
Knowledge-focused Recruiting nowSAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.
Sponsor: Fundación Hipercolesterolemia Familiar • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC